Previous studies have found that in HBV-related hepatocellular carcinoma, the expression of SH2D5 is abnormally upregulated, and it promotes the proliferation and metastatic ability of cells [22]. This evidence concerns the gene SH2D5 and hepatocellular carcinoma.